Specialty Cardiometabolic Rare-Disease Launch Rep

Syneos Health, Inc.; Augusta (GA); On-site; USD 160,000 - 180,000; Full time

Benefits offered by this job

Equity (RSUs)

Car allowance

Health, dental, vision

Job summary

Arrowhead Pharmaceuticals is seeking a Specialty Sales Representative to drive the launch and growth of cardiometabolic therapies in the Augusta area. You will activate prescribers, articulate complex clinical data, and differentiate Arrowhead therapies within a competitive landscape.

The role requires strong field leadership, strategic planning, and collaboration with Market Access and Patient Services to ensure sustained therapy adoption across IDNs. Travel up to 30% may be required.

Qualifications

• Bachelor's degree or equivalent with minimum 5 years of pharmaceutical sales experience.
• Experience launching or expanding complex therapies requiring access navigation and clinical depth.
• 3+ years in specialty, rare disease, or cardiovascular areas preferred.
• Experience with IDNs or complex healthcare systems preferred.

Responsibilities

• Develop and execute data-driven territory business plans aligned to brand strategy.
• Analyze prescribing trends, access landscape and identify growth opportunities.
• Manage budget including speaker programs and promotional initiatives.
• Deliver compliant, clinically accurate product education to prescribers.
• Build relationships with healthcare professionals and institutional stakeholders.
• Collaborate with Marketing, Medical Affairs, and Market Access across accounts.

Skills

Territory planning

Account management

Clinical data interpretation

Communication skills

Relationship building

Strategic growth

Education

Bachelor's degree or equivalent

Tools

CRM software

Job description

Arrowhead Pharmaceuticals is seeking a Specialty Sales Representative to drive the launch and growth of cardiometabolic therapies in the Augusta area. You will activate prescribers, articulate complex clinical data, and differentiate Arrowhead therapies within a competitive landscape.

The role requires strong field leadership, strategic planning, and collaboration with Market Access and Patient Services to ensure sustained therapy adoption across IDNs. Travel up to 30% may be required.